Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.
2.

Epilepsy and concomitant obsessive-compulsive disorder.

Bird JS, Shah E, Shotbolt P.

Epilepsy Behav Case Rep. 2018 Jul 20;10:106-110. doi: 10.1016/j.ebcr.2018.07.001. eCollection 2018.

3.

Deep Brain Stimulation of the Memory Circuit: Improving Cognition in Alzheimer's Disease.

Posporelis S, David AS, Ashkan K, Shotbolt P.

J Alzheimers Dis. 2018;64(2):337-347. doi: 10.3233/JAD-180212. Review.

PMID:
29865076
4.

Incidence and outcome of functional stroke mimics admitted to a hyperacute stroke unit.

Gargalas S, Weeks R, Khan-Bourne N, Shotbolt P, Simblett S, Ashraf L, Doyle C, Bancroft V, David AS.

J Neurol Neurosurg Psychiatry. 2017 Jan;88(1):2-6. doi: 10.1136/jnnp-2015-311114. Epub 2015 Aug 28.

PMID:
26319438
5.

Does human presynaptic striatal dopamine function predict social conformity?

Stokes PR, Benecke A, Puraite J, Bloomfield MA, Shotbolt P, Reeves SJ, Lingford-Hughes AR, Howes O, Egerton A.

J Psychopharmacol. 2014 Mar;28(3):237-43. doi: 10.1177/0269881113512037. Epub 2013 Nov 20.

PMID:
24257812
6.

Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study.

McCormack R, Moriarty J, Mellers JD, Shotbolt P, Pastena R, Landes N, Goldstein L, Fleminger S, David AS.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):895-900. doi: 10.1136/jnnp-2013-305716. Epub 2013 Oct 11.

PMID:
24124043
7.

Pathological crying after subthalamic nucleus stimulation.

Pariwatcharakul P, Clough C, Shotbolt P, Morris R, Hulse N, Costello A, Samuel M, Ashkan K.

Mov Disord. 2013 Sep;28(10):1348-9. doi: 10.1002/mds.25517. Epub 2013 Jul 18. No abstract available.

PMID:
23868460
8.

Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography.

Comley RA, Salinas CA, Slifstein M, Petrone M, Marzano C, Bennacef I, Shotbolt P, Van der Aart J, Neve M, Iavarone L, Gomeni R, Laruelle M, Gray FA, Gunn RN, Rabiner EA.

J Pharmacol Exp Ther. 2013 Aug;346(2):311-7. doi: 10.1124/jpet.112.202895. Epub 2013 May 17.

PMID:
23685546
9.

Deep brain stimulation: a return journey from psychiatry to neurology.

Ashkan K, Shotbolt P, David AS, Samuel M.

Postgrad Med J. 2013 Jun;89(1052):323-8. doi: 10.1136/postgradmedj-2012-131520. Epub 2013 Mar 15. Review.

PMID:
23503892
10.

Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography.

Tziortzi AC, Haber SN, Searle GE, Tsoumpas C, Long CJ, Shotbolt P, Douaud G, Jbabdi S, Behrens TE, Rabiner EA, Jenkinson M, Gunn RN.

Cereb Cortex. 2014 May;24(5):1165-77. doi: 10.1093/cercor/bhs397. Epub 2013 Jan 2.

11.

Nature or nurture? Determining the heritability of human striatal dopamine function: an [18F]-DOPA PET study.

Stokes PR, Shotbolt P, Mehta MA, Turkheimer E, Benecke A, Copeland C, Turkheimer FE, Lingford-Hughes AR, Howes OD.

Neuropsychopharmacology. 2013 Feb;38(3):485-91. doi: 10.1038/npp.2012.207. Epub 2012 Oct 24.

12.

Limbic striatal dopamine D2/3 receptor availability is associated with non-planning impulsivity in healthy adults after exclusion of potential dissimulators.

Reeves SJ, Polling C, Stokes PR, Lappin JM, Shotbolt PP, Mehta MA, Howes OD, Egerton A.

Psychiatry Res. 2012 Apr 30;202(1):60-4. doi: 10.1016/j.pscychresns.2011.09.011. Epub 2012 May 15.

PMID:
22595510
13.

Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neurochemistry and beyond.

Allen P, Modinos G, Hubl D, Shields G, Cachia A, Jardri R, Thomas P, Woodward T, Shotbolt P, Plaze M, Hoffman R.

Schizophr Bull. 2012 Jun;38(4):695-703. doi: 10.1093/schbul/sbs066. Epub 2012 Apr 25. Review.

14.

Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations.

Howes OD, Shotbolt P, Bloomfield M, Daalman K, Demjaha A, Diederen KM, Ibrahim K, Kim E, McGuire P, Kahn RS, Sommer IE.

Schizophr Bull. 2013 Jul;39(4):807-14. doi: 10.1093/schbul/sbr195. Epub 2012 Jan 26.

15.

Relationships between deep brain stimulation and impulse control disorders in Parkinson's disease, with a literature review.

Shotbolt P, Moriarty J, Costello A, Jha A, David A, Ashkan K, Samuel M.

Parkinsonism Relat Disord. 2012 Jan;18(1):10-6. doi: 10.1016/j.parkreldis.2011.08.016. Epub 2011 Sep 14. Review.

PMID:
21920794
16.

Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans.

Shotbolt P, Tziortzi AC, Searle GE, Colasanti A, van der Aart J, Abanades S, Plisson C, Miller SR, Huiban M, Beaver JD, Gunn RN, Laruelle M, Rabiner EA.

J Cereb Blood Flow Metab. 2012 Jan;32(1):127-36. doi: 10.1038/jcbfm.2011.115. Epub 2011 Aug 31.

17.

Striatal dopamine synthesis capacity in twins discordant for schizophrenia.

Shotbolt P, Stokes PR, Owens SF, Toulopoulou T, Picchioni MM, Bose SK, Murray RM, Howes OD.

Psychol Med. 2011 Nov;41(11):2331-8. doi: 10.1017/S0033291711000341. Epub 2011 Mar 22.

PMID:
21426628
18.

Quetiapine in the treatment of psychosis in Parkinson's disease.

Shotbolt P, Samuel M, David A.

Ther Adv Neurol Disord. 2010 Nov;3(6):339-50. doi: 10.1177/1756285610389656.

19.

A randomized controlled trial of quetiapine for psychosis in Parkinson's disease.

Shotbolt P, Samuel M, Fox C, David AS.

Neuropsychiatr Dis Treat. 2009;5:327-32. Epub 2009 Jun 10.

20.

Psychosis in Parkinson's disease: how should we treat it?

Shotbolt P, Samuel M, Anthony D.

Expert Rev Neurother. 2006 Sep;6(9):1243-6. No abstract available.

PMID:
17009911

Supplemental Content

Loading ...
Support Center